4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Usman Sumo Friend Tambunan, Rizky Archintya Rachmania, Arli Aditya Parikesit. In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1[J]. The Journal of Biomedical Research, 2015, 29(2): 150-159. DOI: 10.7555/JBR.29.20130024
Citation: Usman Sumo Friend Tambunan, Rizky Archintya Rachmania, Arli Aditya Parikesit. In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1[J]. The Journal of Biomedical Research, 2015, 29(2): 150-159. DOI: 10.7555/JBR.29.20130024

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1

  • This research focused on the modification of the functional groups of oseltamivir as neuraminidase inhibitor against influenza A virus subtype H1N1. Interactions of three of the best ligands were evaluated in the hydrated state using molecular dynamics simulation at two different temperatures. The docking result showed that AD3BF2D ligand (N-(1S,6R)-5-amino-5-(2R,3S,4S)-3,4-dihydroxy-4-(hydroxymethyl) tetrahydrofuran-2- yloxy-4-formylcyclohex-3-en-1-ylacetamide-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate) had better binding energy values than standard oseltamivir. AD3BF2D had several interactions, including hydrogen bonds, with the residues in the catalytic site of neuraminidase as identified by molecular dynamics simulation. The results showed that AD3BF2D ligand can be used as a good candidate for neuraminidase inhibitor to cope with influenza A virus subtype H1N1.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return